adenine has been researched along with Hepatitis C, Chronic in 33 studies
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment of chronic hepatitis C in patients coinfected with HIV is a complex problem associated with toxicities and drug interactions between HIV antiretrovirals and interferon and ribavirin." | 7.79 | Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients. ( Funk, EK; Heytens, L; Kohli, A; Kottilil, S; Kwan, R; Masur, H; Nelson, A; Polis, MA; Shaffer, A; Shivakumar, B; Sneller, M, 2013) |
| "Psoriasis is a chronic, inflammatory disease affecting 2-3% of the worldwide population, and it may worsen with HIV or be detected as HIV cutaneous manifestation." | 6.48 | Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir). ( Cannizzaro, MV; Chimenti, S; Chiricozzi, A; Giunta, A; Nisticò, SP; Saraceno, R, 2012) |
| " The treatment of choice in chronic hepatitis C currently is pegylated interferon plus ribavirin." | 4.83 | Chronic Hepatitis B and C--current treatment and future therapeutic prospects. ( Müller, C, 2006) |
| " Chronic hepatitis C can be treated preferably with a combination therapy (pegylated interferons + Ribavirin)." | 4.82 | [Hepatitis: associated diseases. Risk groups -- prevention -- treatment]. ( Maier, KP, 2003) |
| " The conference issued recommendations on the investigation and management of chronic hepatitis B, including the use of lamivudine, adefovir and interferon." | 4.82 | The management of chronic viral hepatitis: a Canadian consensus conference 2004. ( Bain, V; Cooper, C; Lowe, C; Martin, S; Myers, RP; Sherman, M; Villeneuve, JP, 2004) |
| " Treatment of chronic hepatitis C in patients coinfected with HIV is a complex problem associated with toxicities and drug interactions between HIV antiretrovirals and interferon and ribavirin." | 3.79 | Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients. ( Funk, EK; Heytens, L; Kohli, A; Kottilil, S; Kwan, R; Masur, H; Nelson, A; Polis, MA; Shaffer, A; Shivakumar, B; Sneller, M, 2013) |
| "In children, the natural history of chronic hepatitis B and C is different from that in adults." | 2.49 | [Treatment of viral hepatitis in children]. ( Kekez, AJ, 2013) |
| "Those at risk for liver disease progression are usually treated with a combination of interferon (IFN) and ribavirin (RBV), which is not highly effective; it has low rates of sustained virologic response (SVR), especially for coinfected patients with HCV genotype 1 and those of African descent." | 2.48 | Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. ( Naggie, S; Sulkowski, MS, 2012) |
| "Psoriasis is a chronic, inflammatory disease affecting 2-3% of the worldwide population, and it may worsen with HIV or be detected as HIV cutaneous manifestation." | 2.48 | Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir). ( Cannizzaro, MV; Chimenti, S; Chiricozzi, A; Giunta, A; Nisticò, SP; Saraceno, R, 2012) |
| "Hepatitis B is a major public health problem in the world today." | 2.43 | Hepatitis B: the pathway to recovery through treatment. ( Hollinger, FB; Lau, DT, 2006) |
| " IFN therapy requires dosage reduction and close monitoring in patients with a GFR <50 ml/min/1." | 1.37 | Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects? ( Bob, F; Bozdog, G; Cioca, D; Curescu, M; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Kaycsa, A; Petrica, L; Sporea, I; Velciov, S; Vernic, C, 2011) |
| "A total of 44 chronic hepatitis B (CHB) patients (mean age: 42 +/- 13." | 1.36 | [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases]. ( Akcan, Y; Altindiş, M; Demirdal, T; Demirtürk, N; Gülamber, G; Kalayci, R, 2010) |
| "In this study, we present a case of renal failure in a patient who was on a tenofovir-containing regimen, resulting in extremely high tenofovir exposure and prolonged tenofovir monotherapy." | 1.35 | Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure. ( Beijnen, JH; Huitema, AD; Jansen, RS; Mulder, JW; Smits, PH; Ter Heine, R; van Gorp, EC; Wagenaar, JF, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (48.48) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Surial, B | 1 |
| Cavassini, M | 1 |
| Calmy, A | 1 |
| Fehr, J | 1 |
| Stöckle, M | 1 |
| Bernasconi, E | 1 |
| Roth, B | 1 |
| Fux, CA | 1 |
| Kovari, H | 1 |
| Furrer, H | 1 |
| Rauch, A | 1 |
| Wandeler, G | 1 |
| Leungsuwan, S | 1 |
| Hooi, B | 1 |
| Myint, KS | 1 |
| Brooks, KM | 1 |
| Castillo-Mancilla, JR | 1 |
| Blum, J | 1 |
| Huntley, R | 1 |
| MaWhinney, S | 1 |
| Alexander, K | 1 |
| Kerr, BJ | 1 |
| Ellison, L | 1 |
| Bushman, LR | 1 |
| MacBrayne, CE | 1 |
| Anderson, PL | 1 |
| Kiser, JJ | 1 |
| Funk, EK | 1 |
| Shaffer, A | 1 |
| Shivakumar, B | 1 |
| Sneller, M | 1 |
| Polis, MA | 1 |
| Masur, H | 1 |
| Heytens, L | 1 |
| Nelson, A | 1 |
| Kwan, R | 1 |
| Kottilil, S | 1 |
| Kohli, A | 1 |
| González-Artacho, C | 1 |
| Rodríguez Sicilia, MJ | 1 |
| Alegría-Motte, C | 1 |
| Gómez García, M | 1 |
| Sagnelli, E | 1 |
| Pisaturo, M | 1 |
| Martini, S | 1 |
| Sagnelli, C | 1 |
| Filippini, P | 1 |
| Coppola, N | 1 |
| Chokshi, S | 1 |
| Cooksley, H | 1 |
| Riva, A | 1 |
| Phillips, S | 1 |
| Williams, R | 1 |
| Gaggar, A | 1 |
| Naoumov, NV | 1 |
| Kekez, AJ | 1 |
| Hiramine, S | 1 |
| Sugiyama, M | 1 |
| Furusyo, N | 1 |
| Uto, H | 1 |
| Ido, A | 1 |
| Tsubouchi, H | 1 |
| Watanabe, H | 1 |
| Ueno, Y | 1 |
| Korenaga, M | 1 |
| Murata, K | 1 |
| Masaki, N | 1 |
| Hayashi, J | 1 |
| Thomas, DL | 1 |
| Mizokami, M | 1 |
| Zhao, PW | 1 |
| Ma, L | 1 |
| Ji, HF | 1 |
| Yu, L | 1 |
| Feng, JY | 1 |
| Wang, J | 1 |
| Liu, MY | 1 |
| Jiang, YF | 1 |
| Thong, VD | 1 |
| Wasitthankasem, R | 1 |
| Tangkijvanich, P | 1 |
| Vongpunsawad, S | 1 |
| Poovorawan, Y | 1 |
| Mira, JA | 1 |
| López-Cortés, LF | 1 |
| Barreiro, P | 2 |
| Tural, C | 1 |
| Torres-Tortosa, M | 1 |
| de Los Santos Gil, I | 1 |
| Martín-Rico, P | 1 |
| Ríos-Villegas, MJ | 1 |
| Hernández-Burruezo, JJ | 1 |
| Merino, D | 1 |
| López-Ruz, MA | 1 |
| Rivero, A | 1 |
| Muñoz, L | 1 |
| González-Serrano, M | 1 |
| Collado, A | 1 |
| Macías, J | 1 |
| Viciana, P | 1 |
| Soriano, V | 2 |
| Pineda, JA | 1 |
| Tillmann, H | 1 |
| Patel, K | 1 |
| McHutchison, J | 1 |
| Tuma, P | 1 |
| Vispo, E | 1 |
| Valencia, ME | 1 |
| Moreno, V | 1 |
| Schildgen, O | 1 |
| Ter Heine, R | 1 |
| Huitema, AD | 1 |
| Jansen, RS | 1 |
| Smits, PH | 1 |
| van Gorp, EC | 1 |
| Wagenaar, JF | 1 |
| Beijnen, JH | 1 |
| Mulder, JW | 1 |
| Wörmann, T | 1 |
| Prüfer-Krämer, L | 1 |
| Krämer, A | 1 |
| Ortu, F | 1 |
| Weimer, LE | 1 |
| Floridia, M | 1 |
| Manconi, PE | 1 |
| Kalayci, R | 1 |
| Altindiş, M | 1 |
| Gülamber, G | 1 |
| Demirtürk, N | 1 |
| Akcan, Y | 1 |
| Demirdal, T | 1 |
| Gluhovschi, C | 1 |
| Gadalean, F | 1 |
| Kaycsa, A | 1 |
| Curescu, M | 1 |
| Sporea, I | 1 |
| Gluhovschi, G | 1 |
| Petrica, L | 1 |
| Velciov, S | 1 |
| Bozdog, G | 1 |
| Bob, F | 1 |
| Vernic, C | 1 |
| Cioca, D | 1 |
| Naggie, S | 1 |
| Sulkowski, MS | 2 |
| Chiricozzi, A | 1 |
| Saraceno, R | 1 |
| Cannizzaro, MV | 1 |
| Nisticò, SP | 1 |
| Chimenti, S | 1 |
| Giunta, A | 1 |
| Iino, S | 1 |
| Maier, KP | 2 |
| Sterling, RK | 1 |
| Zhuang, H | 1 |
| Zhou, YH | 1 |
| Ferenci, P | 1 |
| Sherman, M | 1 |
| Bain, V | 1 |
| Villeneuve, JP | 1 |
| Myers, RP | 1 |
| Cooper, C | 1 |
| Martin, S | 1 |
| Lowe, C | 1 |
| Hollinger, FB | 1 |
| Lau, DT | 1 |
| Müller, C | 1 |
| Dalmi, L | 1 |
| Gervain, J | 1 |
| Horváth, G | 1 |
| Hunyady, B | 1 |
| Ibrányi, E | 1 |
| Makara, M | 1 |
| Pár, A | 1 |
| Szalay, F | 1 |
| Tornai, I | 1 |
| Telegdy, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-Label, Randomized Study to Determine the Impact of Antiretroviral Treatment in HCV/HIV-Coinfected Subjects With High CD4+ Cell Count on the Efficacy of Hepatitis C Treatment With Pegylated Interferon Alfa-2A and Ribavirin[NCT00100581] | 2 participants (Actual) | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for adenine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Topics: Adenine; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Guanine; Hepacivirus; | 2014 |
[Treatment of viral hepatitis in children].
Topics: Adenine; Adolescent; Antiviral Agents; Child; Child Welfare; Drug Therapy, Combination; Female; Hepa | 2013 |
[Role of tenofovir in HIV and hepatitis C virus coinfection].
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug | 2008 |
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease | 2012 |
Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir).
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Deoxycytidine; | 2012 |
[Antiviral therapy for chronic viral hepatitis B and C].
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon a | 2003 |
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B S | 2003 |
Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
Topics: Adenine; Antiviral Agents; Comorbidity; Hepacivirus; Hepatitis B virus; Hepatitis C; Hepatitis C, Ch | 2004 |
Treatment of chronic viral hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; He | 2004 |
The management of chronic viral hepatitis: a Canadian consensus conference 2004.
Topics: Adenine; Adult; Antiviral Agents; Canada; Child; Child, Preschool; Drug Therapy, Combination; Enzyme | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
Hepatitis B: the pathway to recovery through treatment.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis C, Chronic; Human | 2006 |
Chronic Hepatitis B and C--current treatment and future therapeutic prospects.
Topics: Adenine; Antiviral Agents; DNA-Directed RNA Polymerases; Hepatitis B e Antigens; Hepatitis B, Chroni | 2006 |
2 trials available for adenine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Cytokines; Female; Hepatitis B e Antigens; Hepatit | 2014 |
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
Topics: Adenine; Adult; Anti-HIV Agents; Blood; Cohort Studies; Deoxycytidine; Dideoxynucleosides; Emtricita | 2008 |
18 other studies available for adenine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Interactions; F | 2019 |
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hy | 2020 |
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir.
Topics: Adenine; Adolescent; Adult; Antiviral Agents; Benzimidazoles; Blood Chemical Analysis; Chromatograph | 2019 |
Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.
Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Com | 2013 |
[Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents].
Topics: Adalimumab; Adenine; Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azathioprine; Crohn | 2014 |
A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus.
Topics: Adenine; Adolescent; Adult; Aged; Alleles; Dinucleotide Repeats; DNA, Viral; Female; Gene Frequency; | 2015 |
The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy.
Topics: Adenine; Adult; Aged; Antibodies, Monoclonal; Antiviral Agents; B-Lymphocytes; B7-2 Antigen; DNA, Vi | 2015 |
Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
Topics: Adenine; Adult; Alleles; Antiviral Agents; Asian People; Case-Control Studies; Dinucleotide Repeats; | 2015 |
Hepatitis B virus viral load and treatment decision.
Topics: Adenine; Algorithms; Antiviral Agents; Decision Making; DNA, Viral; Drug Resistance, Viral; Female; | 2009 |
[Atazanavir-induced nephrolithiasis].
Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cy | 2009 |
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepa | 2009 |
Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure.
Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; HI | 2009 |
[Serological and sociodemographic differences in HBV-patients with and without migration background].
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Comorbidity; Cross-Sectional Studies; Edu | 2010 |
Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity.
Topics: Adenine; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury | 2010 |
[Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA Mutational Analysis; DNA-Directed DNA Polyme | 2010 |
Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
Topics: Adenine; Adult; Albuminuria; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B, Chron | 2011 |
[Active prevention and treatment of superinfection with HBV, HCV and HIV].
Topics: Adenine; Antiretroviral Therapy, Highly Active; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infe | 2004 |
[Protocol for the treatment of chronic viral hepatitis].
Topics: Adenine; Algorithms; Antiviral Agents; Clinical Protocols; Hepacivirus; Hepatitis B virus; Hepatitis | 2008 |